Osaka U YAP-CTGF Axis Prevents Liver Fibrosis | AcademicJobs
Osaka University uncovers integrin αV-YAP-CTGF axis in LSECs driving fibrosis in congestive hepatopathy, offering new targets to halt portal hypertension and liver cancer progression.
No reviews yet. Be the first to rate Seiya!
Seiya Kato, MD, is affiliated with the Department of Gastroenterology and Hepatology at the Graduate School of Medicine, Osaka University. His research focuses on liver diseases, including mechanisms of liver fibrogenesis and related pathways in congestive hepatopathy. He has contributed as lead author to publications such as the 2026 paper in Gastroenterology on the activation of the integrin αV–YAP–CTGF axis in liver sinusoidal endothelial cells.
In 2024, Kato received an AASLD Foundation Abstract Award for work on hepatic congestion and liver pathogenesis. He is also a co-author on additional studies examining serum markers and tumor-stroma interactions in gastroenterology and hepatology contexts at Osaka University.
Professional Email: null
Osaka University uncovers integrin αV-YAP-CTGF axis in LSECs driving fibrosis in congestive hepatopathy, offering new targets to halt portal hypertension and liver cancer progression.
Photo by Mufid Majnun on Unsplash
Photo by Shubham Sharan on Unsplash
Photo by Shubham Sharan on Unsplash
Photo by Evan Marvell on Unsplash
Photo by Markus Winkler on Unsplash
Photo by Patrick Robert Doyle on Unsplash
Photo by Brandi Redd on Unsplash
Have a story or a research paper to share? Become an Expert Academic Contributor and publish your work on AcademicJobs.com.
Write news and research articles as a expert academic in your field publish your work on AcademicJobs.com
